The duration of antigen-stimulation significantly alters the diversity of multifunctional CD4 T cells measured by intracellular cytokine staining

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Kaveh, Daryan A ^a   Whelan, Adam O ^a   Hogarth, Philip J ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; BOVINE TUBERCULOSIS; CD4+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOSTIMULATION; IN VITRO STUDY; INTRACELLULAR CYTOKINE STAINING; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; STAINING; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS; BCG VACCINE; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; MICE; STAINING AND LABELING; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84862225435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038926     Document Type: Article

References (47)

1. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
2. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, et al. (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15: 293-299.
3. Kohlmeier JE, Woodland DL, (2009) Immunity to respiratory viruses. Annu Rev Immunol 27: 61-82.
4. Madhun AS, Haaheim LR, Nostbakken JK, Ebensen T, Chichester J, et al. (2011) Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice. Vaccine 29: 4973-4982.
5. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
6. Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, et al. (2008) Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 181: 4955-4964.
7. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, et al. (2009) Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 182: 8047-8055.
8. Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, et al. (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17: 189-194.
9. Kaveh DA, Bachy VS, Hewinson RG, Hogarth PJ, (2011) Systemic BCG Immunization Induces Persistent Lung Mucosal Multifunctional CD4 T(EM) Cells which Expand Following Virulent Mycobacterial Challenge. PLoS One 6: e21566.
10. Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, et al. (2008) rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS ONE 3: e3790.
11. Beveridge NE, Price DA, Casazza JP, Pathan AA, Sander CR, et al. (2007) Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 37: 3089-3100.
12. Abel B, Tameris M, Mansoor N, Gelderbloem S, Hughes J, et al. (2010) The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med 181: 1407-1417.
13. Seder RA, Darrah PA, Roederer M, (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247-258.
14. Minassian AM, Rowland R, Beveridge NE, Poulton ID, Satti I, et al. (2011) A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults. BMJ Open 1: e000223.
15. Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, et al. (2011) A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS ONE 6: e21225.
16. Llanos-Cuentas A, Calderon W, Cruz M, Ashman JA, Alves FP, et al. (2010) A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis. Vaccine 28: 7427-7435.
17. Combadiere B, Vogt A, Mahe B, Costagliola D, Hadam S, et al. (2010) Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS ONE 5: e10818.
18. Sander CR, Pathan AA, Beveridge NE, Poulton I, Minassian A, et al. (2009) Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am J Respir Crit Care Med 179: 724-733.
19. Foster B, Prussin C, Liu F, Whitmire JK, Whitton JL, (2007) Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol Chapter 6: Unit 6 24.
20. Lamoreaux L, Roederer M, Koup R, (2006) Intracellular cytokine optimization and standard operating procedure. Nat Protoc 1: 1507-1516.
21. Horton H, Thomas EP, Stucky JA, Frank I, Moodie Z, et al. (2007) Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J Immunol Methods 323: 39-54.
22. Maecker HT, Rinfret A, D'Souza P, Darden J, Roig E, et al. (2005) Standardization of cytokine flow cytometry assays. BMC Immunol 6: 13.
23. Nomura L, Maino VC, Maecker HT, (2008) Standardization and optimization of multiparameter intracellular cytokine staining. Cytometry A 73: 984-991.
24. O'Neil-Andersen NJ, Lawrence DA, (2002) Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A. Clin Diagn Lab Immunol 9: 243-250.
25. Machamer CE, Cresswell P, (1984) Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex. Proc Natl Acad Sci U S A 81: 1287-1291.
26. Adorini L, Ullrich SJ, Appella E, Fuchs S, (1990) Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells. Nature 346: 63-66.
27. Yewdell JW, Bennink JR, (1989) Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244: 1072-1075.
28. Billeskov R, Grandal MV, Poulsen C, Christensen JP, Winther N, et al. (2010) Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis. Eur J Immunol 40: 1342-1354.
29. Hervas-Stubbs S, Majlessi L, Simsova M, Morova J, Rojas MJ, et al. (2006) High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun 74: 3396-3407.
30. Whelan AO, Villarreal-Ramos B, Vordermeier HM, Hogarth PJ, (2011) Development of an Antibody to Bovine IL-2 Reveals Multifunctional CD4 T(EM) Cells in Cattle Naturally Infected with Bovine Tuberculosis. PLoS ONE 6: e29194.
31. Sopp P, Howard CJ, (2001) IFN gamma and IL-4 production by CD4, CD8 and WC1 gamma delta TCR(+) T cells from cattle lymph nodes and blood. Vet Immunol Immunopathol 81: 85-96.
32. Weynants V, Walravens K, Didembourg C, Flanagan P, Godfroid J, et al. (1998) Quantitative assessment by flow cytometry of T-lymphocytes producing antigen-specific gamma-interferon in Brucella immune cattle. Vet Immunol Immunopathol 66: 309-320.
33. Vordermeier HM, Whelan A, Cockle PJ, Farrant L, Palmer N, et al. (2001) Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 8: 571-578.
34. Perfetto SP, Chattopadhyay PK, Lamoreaux L, Nguyen R, Ambrozak D, et al. (2010) Amine-reactive dyes for dead cell discrimination in fixed samples. Curr Protoc Cytom Chapter 9: Unit 9 34.
35. Perfetto SP, Chattopadhyay PK, Lamoreaux L, Nguyen R, Ambrozak D, et al. (2006) Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J Immunol Methods 313: 199-208.
36. Gauduin MC, Kaur A, Ahmad S, Yilma T, Lifson JD, et al. (2004) Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T cell responses in rhesus macaques. J Immunol Methods 288: 61-79.
37. Huse M, Quann EJ, Davis MM, (2008) Shouts, whispers and the kiss of death: directional secretion in T cells. Nat Immunol 9: 1105-1111.
38. Villarino AV, Katzman SD, Gallo E, Miller O, Jiang S, et al. (2011) Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells. Immunity 34: 50-60.
39. Scheu S, Stetson DB, Reinhardt RL, Leber JH, Mohrs M, et al. (2006) Activation of the integrated stress response during T helper cell differentiation. Nat Immunol 7: 644-651.
40. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, et al. (2003) Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 198: 1069-1076.
41. Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM, (2006) T cells use two directionally distinct pathways for cytokine secretion. Nat Immunol 7: 247-255.
42. Nomura LE, Walker JM, Maecker HT, (2000) Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells. Cytometry 40: 60-68.
43. Chattopadhyay PK, Yu J, Roederer M, (2006) Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Nat Protoc 1: 1-6.
44. Koguchi Y, Thauland TJ, Slifka MK, Parker DC, (2007) Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood 110: 2520-2527.
45. Meier S, Stark R, Frentsch M, Thiel A, (2008) The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells. Cytometry A 73: 1035-1042.
46. Hanekom WA, Dockrell HM, Ottenhoff TH, Doherty TM, Fletcher H, et al. (2008) Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med 5: e145.
47. Vordermeier HM, Dean GS, Rosenkrands I, Agger EM, Andersen P, et al. (2009) Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model. Clin Vaccine Immunol 16: 1443-1448.